These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24390492)

  • 1. A novel blending method for dispensing powdered medicine.
    Miyazaki Y; Miyawaki K; Uchino T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):54-7. PubMed ID: 24390492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Response Surface Methodology to Estimate the Design Space of Pharmaceutical Diluents for Dispensing Powdered Formulations.
    Miyazaki Y; Takayama K; Uchino T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2016; 64(12):1698-1706. PubMed ID: 27904079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blending powdered antineoplastic medicine in disposable ointment container].
    Miyazaki Y; Uchino T; Kagawa Y
    Yakugaku Zasshi; 2014; 134(5):665-70. PubMed ID: 24790050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of blending ratio of powdered medicine mixtures by image analysis.
    Miyazaki Y; Miyawaki K; Uchino T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2014; 62(4):322-7. PubMed ID: 24695341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of degree of blending colored diluents using color difference signal method.
    Miyazaki Y; Uchino T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2014; 62(5):488-90. PubMed ID: 24789932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry Powder Coating using Planetary Centrifugal Mixer.
    Miyazaki Y; Miyawaki K; Uchino T; Kagawa Y
    J Pharm Pharm Sci; 2015; 18(3):460-73. PubMed ID: 26517137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of electrostatic charging on pharmaceutical powder blending homogeneity.
    Pu Y; Mazumder M; Cooney C
    J Pharm Sci; 2009 Jul; 98(7):2412-21. PubMed ID: 18855912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation.
    El-Hagrasy AS; D'Amico F; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):392-406. PubMed ID: 16381014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixing of low-dose cohesive drug and overcoming of pre-blending step using a new gentle-wing high-shear mixer granulator.
    Alsulays BB; Fayed MH; Alalaiwe A; Alshahrani SM; Alshetaili AS; Alshehri SM; Alanazi FK
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1520-1527. PubMed ID: 29718720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
    De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
    J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of operational parameters and feed preparation in a convective batch ribbon powder mixer.
    Yeow ST; Shahar A; Abdul Aziz N; Anuar MS; Yusof YA; Taip FS
    Drug Des Devel Ther; 2011; 5():465-9. PubMed ID: 22162640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process characterization of powder blending by near-infrared spectroscopy: blend end-points and beyond.
    Shi Z; Cogdill RP; Short SM; Anderson CA
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):738-45. PubMed ID: 18486399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content].
    Liang ZL; Wang XH; Ni R; Zhang L; Muenster U; Mao SR
    Yao Xue Xue Bao; 2015 Sep; 50(9):1180-5. PubMed ID: 26757557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Dantrolene Granules Extemporaneously Reformulated from Capsules in a Pharmacy.
    Miyazaki Y; Tsuboi A; Maruyama S; Aoshima H; Uchino T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2020; 68(10):989-995. PubMed ID: 32999151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending: Part II: Qualitative near-infrared models for prediction of blend homogeneity.
    El-Hagrasy AS; Delgado-Lopez M; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):407-21. PubMed ID: 16380974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.